Galanin Receptors as Drug Target for Novel Antidepressants: Review

QR Code

Galanin Receptors as Drug Target for Novel Antidepressants: Review

Desalegn Getnet Demsie,1 Birhanetensay Masresha Altaye,2 Etsay Weldekidan,1 Hagazi Gebremedhin,1 Niguse Meles Alema,3 Mulugeta Mihrete Tefera,3 Abere Tilahun Bantie4 1College of Medicine and Health Sciences, Department of Pharmacy, Adigrat University, Adigrat, Ethiopia; 2College of Health Sciences,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	galanin depression galanin receptors Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/f7df9e2cd2024a7f855b56ad4fee7d18
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Potential role of galanine in the treatment of type 2 diabetes mellitus
par: Igor Vladimirovich Dobrokhotov, et autres
Publié: (2020)

Association Between Polymorphisms in the 5′ Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case–Control Study
par: Li Y, et autres
Publié: (2020)

Antidepressant effects of an inverse agonist selective for α5 GABA-A receptors in the rat forced swim test
par: Samardžić Janko, et autres
Publié: (2014)

Glycopeptides as Potential Interventions for COVID-19
par: Demsie DG, et autres
Publié: (2020)

Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia
par: Tsegay EW, et autres
Publié: (2020)

Drug–drug interactions involving antidepressants: focus on desvenlafaxine
par: Low Y, et autres
Publié: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
par: Michael Colla, et autres
Publié: (2021)

Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
par: L. K. Khokhlov, et autres
Publié: (2019)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
par: Naghmeh Nikkheslat
Publié: (2021)

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
par: Engel T, et autres
Publié: (2021)

Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model
par: Susanne M. Brunner, et autres
Publié: (2021)

Immunoregulation and antidepressant effect of ketamine
par: Zhang Nan, et autres
Publié: (2021)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
par: O. V. Petrunko
Publié: (2014)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
par: Dhaiban S, et autres
Publié: (2020)

In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications
par: Hua S, et autres
Publié: (2019)

Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
par: Mateusz Kowalczyk, et autres
Publié: (2021)

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
par: Lunghi C, et autres
Publié: (2020)

Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors
par: FARRELL,EMILY F, et autres
Publié: (2004)

Receptor-Mediated NETosis on Neutrophils
par: Tao Chen, et autres
Publié: (2021)

Nuclear receptor
Publié: (2003)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
par: Blat Diana, et autres
Publié: (2021)

Galanin neurons in the ventrolateral preoptic area promote sleep and heat loss in mice
par: Daniel Kroeger, et autres
Publié: (2018)

Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
par: Soraia Silva, et autres
Publié: (2021)

Antidepressant therapy in complex treatment of painful diabetic polyneuropathy
par: Lidia Grigor'evna Turbina, et autres
Publié: (2012)

Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
par: Yixiao Luo, et autres
Publié: (2021)

Additive Antidepressant Effects of Combined Administration of Ecitalopram and Caloric Restriction in LPS-Induced Neonatal Model of Depression in Rats
par: Haritov E., et autres
Publié: (2020)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
par: Bhattacharjee S, et autres
Publié: (2020)

Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer
par: Gao W, et autres
Publié: (2017)

Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier
par: Zhang L, et autres
Publié: (2018)

Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity
par: Mohyeldin SM, et autres
Publié: (2021)

Src family kinases activity is required for transmitting purinergic P2X7 receptor signaling in cortical spreading depression and neuroinflammation
par: Lingdi Nie, et autres
Publié: (2021)

Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
par: Vasilescu AN, et autres
Publié: (2017)

THEORETICAL STUDY OF THE OPIOID RECEPTOR SELECTIVITY OF SOME 7-ARYLIDENENALTREXONES
par: Gómez-Jeria,Juan S, et autres
Publié: (2003)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
par: McIntyre RS
Publié: (2017)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
par: Larisa Duffy, et autres
Publié: (2021)

Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma
par: Paula Aldaz, et autres
Publié: (2021)

Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence
par: Gui-Ying Zan, et autres
Publié: (2021)

Neuropathic pain: targeting the melatonin MT<sub>2</sub> receptor
par: N. Smith, et autres
Publié: (2016)

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
par: Casneuf T, et autres
Publié: (2016)